Phase I/II study of trastuzumab, pertuzumab, palbociclib and fulvestrant in patients with HER2-positive and hormone receptor positive metastatic breast cancer

MedStar author(s):
Citation: Unpublished 2016/03/14Form of publication: Poster PresentationYear: 2016Conference information: Washington Cancer Institute: MedStar Health Research Symposium, Columbia, MD, All authors: Herbolsheimer P, Riggins R, Pohlmann P, ElChaarani B, Isaacs C, Cai L, Swain SM Fiscal year: FY2016Local accession number: 2016_98Date added to catalog: 2017-05-06
Holdings
Item type Current library Collection Call number Status Date due Barcode
Poster Presentation MedStar Authors Catalog Poster Available

Powered by Koha